Broad-Shouldered Survival Curves of a Human Melanoma Xenograft Implications for radiation therapy in the absence and presence of misonidazole

References

• Adams G. E., Flockhart I. R., Smithen C. E., Stratford I. J., Wardman P., Watts M. E. Electron‐affinic sensitization. VII. A correlation between structures, one‐electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat. Res. 1976; 67: 9
   PubMed Web of Science ®Google Scholar
• Asquith J. C., Watts M. E., Patel K., Smithen C. E., Adams G. E. Electron‐affinic sensitization. V. Radiosensitization of hypoxic bacterial and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat. Res. 1974; 60: 108
   PubMed Web of Science ®Google Scholar
• Barranco S. C., Romsdahl M. M., Humphrey R. M. The radiation response of human malignant melanoma cells grown in vitro. Cancer Res. 1971; 31: 830
   PubMed Web of Science ®Google Scholar
• Denekamp J., McNally N. J., Fowler J. F., Joiner M. C. Misonidazole in fractionated radiotherapy. Are many small fractions best. Brit. J. Radiol. 1980; 53: 981
   PubMed Web of Science ®Google Scholar
• Dewey D. L. The radiosensitivity of melanoma cells in culture. Brit. J. Radiol. 1971; 44: 816
   PubMed Web of Science ®Google Scholar
• Dische S., Saunders M. I., Flockhart I. R., Lee M. E., Anderson P. Misonidazole. A drug for trial in radiotherapy and oncology. Int. J. Radiat. Oncol. Biol. Phys. 1979; 5: 851
   PubMed Web of Science ®Google Scholar
• Dische S., Saunders M. I., Lee M. E., Adams G. E., Flockhart I. R. Clinical testing of the radiosensitizer Ro–07–0582. Experience with multiple doses. Brit. J. Cancer 1977; 35: 567
   PubMed Web of Science ®Google Scholar
• Elkind M. M. The initial part of the survival curve. Implications for low‐dose, low‐dose‐rate radiation responses. Radiat. Res. 1977; 71: 9
   PubMed Web of Science ®Google Scholar
• Ellis F. The NSD concept and radioresistant tumours. Brit. J. Radiol. 1974; 47: 909
   PubMedGoogle Scholar
• Flaten T. P., Rofstad E. K., Brustad T. Radiation response of two human malignant melanomas grown in athymic nude mice. Europ. J. Cancer 1981; 17: 527
   PubMed Web of Science ®Google Scholar
• Habermalz H. J., Fischer J. J. Radiation therapy of malignant melanoma. Experience with high individual treatment doses. Cancer 1976; 38: 2258
   PubMed Web of Science ®Google Scholar
• Hornsey S. The relationship between total dose, number of fractions and fraction size in the response of malignant melanoma in patients. Brit. J. Radiol. 1978; 51: 905
   PubMed Web of Science ®Google Scholar
• McNally N. J. Fractionated radiotherapy of tumour cells possessing wide‐shouldered survival curves and capable of reoxygenation. Brit. J. Radiol. 1980; 53: 703
   PubMed Web of Science ®Google Scholar
• McNally N. J., Sheldon P. W. The effect of radiation on tumour growth delay, cell survival and cure of the animal using a single tumour system. Brit. J. Radiol. 1977; 50: 321
   PubMed Web of Science ®Google Scholar
• McNally N. J., Denekamp J., Sheldon P., Flockhart I. R., Stewart F. A. Radiosensitization by misonidazole (Ro–07–0582). The importance of timing and tumor concentration of sensitizer. Radiat. Res. 1978; 73: 568
   PubMedGoogle Scholar
• Overgaard J. Radiation treatment of malignant melanoma. Int. J. Radiat. Oncol. Biol. Phys. 1980; 6: 41
   PubMed Web of Science ®Google Scholar
• Rofstad E. K. Radiation response of the cells of a human malignant melanoma xenograft. Effect of hypoxic cell radiosensitizers. Radiat. Res. 1981; 87: 670
   PubMed Web of Science ®Google Scholar
• Rofstad E. K., Brustad T. The radiosensitizing effect of metronidazole and misonidazole (Ro–07–0582) on a human malignant melanoma grown in the athymic mutant nude mouse. Brit. J. Radiol. 1978; 51: 381
   PubMed Web of Science ®Google Scholar
• Rofstad E. K., Brustad T. Radiosensitizing effect of misonidazole in fractionated gamma‐ray treatment of a human malignant melanoma grown in athymic nude mice. Brit. J. Radiol. 1979; 52: 393
   PubMedGoogle Scholar
• Rofstad E. K., Brustad T. Radiosensitization by misonidazole of a human malignant melanoma grown in athymic nude mice. Brit. J. Radiol. 1980; 53: 678
   PubMedGoogle Scholar
• Rofstad E. K., Brustad T., Johannessen J. V. Effect of clinically relevant irradiation regimes on human malignant melanomas grown in athymic nude mice. Acta radiol. Ther. Phys. Biol. 1977; 16: 273, (a)
   PubMed Web of Science ®Google Scholar
• Rofstad E. K., Brustad T., Johannessen J. V., Mossige J. Effect of cobalt‐60 gamma rays and DTIC (5‐(3,3 dimethyl‐1‐triazeno) imidazole‐4‐carboxamide) on human malignant melanomas grown in athymic nude mice. Brit. J. Radiol. 1977; 50: 314, (b)
   PubMed Web of Science ®Google Scholar
• Rofstad E., Lindmo T., Brustad T. Effect of single dose irradiation on the proliferation kinetics in a human malignant melanoma in athymic nude mice. Acta radiol. Oncology 1980; 19: 261
   PubMed Web of Science ®Google Scholar
• Sinclair W. K. Cyclic X‐ray responses in mammalian cells in vitro. Radiat. Res. 1968; 33: 620
   PubMed Web of Science ®Google Scholar
• Weichselbaum R., Little J. B., Nove J. Response of human osteosarcoma in vitro to irradiation. Evidence for unusual cellular repair activity. Int. J. Radiat. Biol. 1977; 31: 295
   Web of Science ®Google Scholar
• Wheldon T. E. Optimal fractionation for the radiotherapy of tumour cells possessing wide‐shouldered survival curves. Brit. J. Radiol. 1979; 52: 417
   PubMed Web of Science ®Google Scholar
• Wheldon T. E., Kirk J. Optimal radiotherapy of radioresistant tumours. Brit. J. Radiol. 1975; 48: 870
   PubMedGoogle Scholar
• Zeitz L., McDonald J. M. Pitfalls in the use of in vitro survival curves for the determination of tumour cell survival with fractionated doses. Brit. J. Radiol. 1978; 51: 637
   PubMedGoogle Scholar